$603.8 Million Worldwide Breast Reconstruction Industry to 2025 - Featuring Allergan, Sientra & Sebbin Among Others
DUBLIN, June 18, 2020 /PRNewswire/ -- The "Breast Reconstruction Market by Product (Breast implant (Silicone, Saline), Tissue Expander, Acellular Dermal Matrix), Procedure (Immediate, Delayed, Revision), Type (Unilateral, Bilateral), End User (Hospital, Cosmetology Clinics) - Global Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.
The breast reconstruction market is expected to reach 603.8 million by 2025 from USD 430.8 million in 2020, at a CAGR of 7.0%.
Growth in this industry is driven by the rising incidences of breast cancer, increasing awareness, and the availability of reimbursements. However, clinical risks and complications associated with breast reconstruction restrain market growth.
The acellular dermal matrix segment is anticipated to grow at the fastest growth rate during the forecast period.
The breast reconstruction market, by product, is categorized into breast implants, tissue expanders, and acellular dermal matrix. The acellular dermal matrix segment is expected to register the highest CAGR during the forecast period. The growth of this segment is mainly driven by the rising incidences of breast cancer, increasing number of mastectomies, and growing use usage of acellular dermal matrices.
The immediate procedure segment is estimated to grow at a rapid rate during the forecast period.
On the basis of procedure, the breast reconstruction market is segmented into immediate, delayed, and revision procedures. Immediate procedures are expected to remain the fastest-growing segment of the global breast reconstruction market during the breast reconstruction period. Factors such as the increasing number of surgeries post-mastectomy and rising awareness are driving the market.
Asia Pacific is estimated to register the highest CAGR during the study period.
Geographically, the breast reconstruction market is dominated by North America and Europe. However, the Asia Pacific market is estimated to grow at the fastest rate during the forecast period.
Key Topics Covered:
1 Introduction
2 Research Methodology
3 Executive Summary
4 Premium Insights
4.1 Breast Reconstruction: Market Overview
4.2 North America: Breast Reconstruction Market, by Product, 2019
4.3 Geographical Snapshot of the Breast Reconstruction Market
5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Rising Incidence of Breast Cancer
5.2.1.2 Increasing Awareness
5.2.1.3 Reimbursements for Breast Reconstruction
5.2.2 Restraints
5.2.2.1 Clinical Risks and Complications of Breast Reconstruction Procedures
5.2.2.2 Alternative Non-Surgical Methods
5.2.3 Opportunities
5.2.3.1 Growth Opportunities in Emerging Markets
5.2.3.2 Development of 3D-Printed Implants
5.2.4 Challenges
5.2.4.1 Product Failures and Recalls
5.3 Pricing Analysis
5.4 Value Chain Analysis
5.5 Ecosystem
5.5.1 Covid-19 Impact on the Breast Reconstruction Market
6 Breast Reconstruction Market, by Product
6.1 Introduction
6.2 Breast Implants
6.2.1 Breast Implants Market, by Type
6.2.1.1 Silicone Implants
6.2.1.1.1 Silicone Breast Implants to Dominate the Breast Implants Market During the Forecast Period
6.2.1.2 Saline Implants
6.2.1.2.1 Low Cost of Implants to Drive Market Growth
6.2.2 Breast Implants Market, by Shape
6.2.2.1 Round Implants
6.2.2.1.1 Round Implants Show the Highest End-User Demand and Market Growth
6.2.2.2 Anatomical Implants
6.2.2.2.1 Increasing Implant-Based Breast Reconstruction Procedure will Support the Market Growth
6.3 Tissue Expanders
6.3.1 Rising Number of Breast Reconstruction Procedures will Support Market Growth
6.4 Acellular Dermal Matrix
6.4.1 Rising Number of Acellular Dermal Matrix Breast Reconstruction Procedures will Support Market Growth
7 Breast Reconstruction Market, by Procedure
7.1 Introduction
7.2 Immediate Procedures
7.2.1 Immediate Procedures Hold Largest Market Share
7.3 Delayed Procedures
7.3.1 Rising Awareness will Support Market Growth
7.4 Revision Procedures
7.4.1 Dissatisfaction and Aesthetic Issues Drive Demand for Revision
8 Breast Reconstruction Market, by Type
8.1 Introduction
8.2 Unilateral Breast Reconstruction
8.2.1 Unilateral Reconstruction Dominates the Market, by Type
8.3 Bilateral
8.3.1 APAC to Show Highest Growth in the Market for Bilateral Breast Reconstruction
9 Breast Reconstruction Market, by End User
9.1 Introduction
9.2 Hospitals
9.2.1 Hospitals to Dominate the Breast Reconstruction Market During the Forecast Period
9.3 Cosmetology Clinics & Ambulatory Surgical Centers
9.3.1 Growing Preference for Outpatient Treatment and Procedures Over Hospital Care Drives Market Growth
9.4 Covid-19 Analysis
10 Breast Reconstruction Market, by Region
10.1 Introduction
10.2 North America
10.2.1 US
10.2.1.1 the US Dominates the North American Breast Reconstruction Market
10.2.2 Canada
10.2.2.1 Increasing Incidence of Breast Cancer will Drive Market Growth in Canada
10.3 Europe
10.3.1 Germany
10.3.1.1 Germany Dominates the European Breast Reconstruction Market
10.3.2 France
10.3.2.1 Rising Geriatric Population will Drive Market Growth
10.3.3 UK
10.3.3.1 Rising Incidences of Breast Cancer will Support Market Growth
10.3.4 Italy
10.3.4.1 Rising Geriatric Population in Italy to Drive the Market
10.3.5 Spain
10.3.5.1 R&D Investments for the Development of Innovative Drugs Form a Key Growth Driver in the Spanish Market
10.3.6 Rest of Europe
10.4 Asia Pacific
10.4.1 China
10.4.1.1 China Accounts for the Largest Share of the APAC Market
10.4.2 Japan
10.4.2.1 Growing Geriatric Population to Drive the Market in Japan
10.4.3 India
10.4.3.1 Market Growth in India is Primarily Driven by the Rising Incidence of Breast Cancer
10.4.4 Rest of Asia Pacific
10.5 Rest of the World
11 Competitive Landscape
11.1 Overview
11.2 Market Share Analysis, 2019
11.3 Competitive Scenario
11.3.1 Product Launches and Approvals
11.3.2 Partnerships, Collaborations, Mergers, and Agreements
11.3.3 Expansions
11.3.4 Acquisitions
11.3.5 Other Developments
11.4 Competitive Leadership Mapping (2018)
11.4.1 Visionary Leaders
11.4.2 Innovators
11.4.3 Dynamic Differentiators
11.4.4 Emerging Companies
12 Company Profiles
12.1 Johnson & Johnson
12.2 Allergan
12.3 Sientra
12.4 Polytech Health & Aesthetics
12.5 GC Aesthetics
12.6 Sebbin
12.7 Ideal Implant Incorporated
12.8 Establishment Labs S.a.
12.9 Integra Lifesciences
12.10 Laboratories Arion
12.11 Silimed
12.12 Guangzhou Wanhe Plastic Materials
12.13 Cereplas
12.14 Hansbiomed
12.15 RTI Surgical Holdings
12.16 Shanghai Kangning Medical Device
12.17 PMT Corporation
For more information about this report visit https://www.researchandmarkets.com/r/123ctd
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets
Share this article